KRW 5670.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1078.06 Billion KRW | 15.67% |
2022 | 932.02 Billion KRW | 5.45% |
2021 | 883.84 Billion KRW | 6.4% |
2020 | 830.64 Billion KRW | 4.78% |
2019 | 792.77 Billion KRW | 8.29% |
2018 | 732.05 Billion KRW | 1.29% |
2017 | 722.69 Billion KRW | 6.31% |
2016 | 679.78 Billion KRW | 2.41% |
2015 | 663.78 Billion KRW | 50.0% |
2014 | 442.52 Billion KRW | 3.96% |
2013 | 425.67 Billion KRW | 9.31% |
2012 | 389.43 Billion KRW | 21.06% |
2011 | 321.68 Billion KRW | 10.28% |
2010 | 291.68 Billion KRW | 10.52% |
2009 | 263.92 Billion KRW | 6.92% |
2008 | 246.84 Billion KRW | 3.8% |
2007 | 237.81 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1135.6 Billion KRW | 2.64% |
2024 Q1 | 1106.42 Billion KRW | 2.63% |
2023 Q2 | 988.71 Billion KRW | 3.15% |
2023 Q3 | 1011.87 Billion KRW | 2.34% |
2023 Q4 | 1078.06 Billion KRW | 6.54% |
2023 FY | 1078.06 Billion KRW | 15.67% |
2023 Q1 | 958.56 Billion KRW | 2.85% |
2022 Q4 | 932.02 Billion KRW | 2.98% |
2022 Q3 | 905.03 Billion KRW | 0.83% |
2022 Q2 | 897.55 Billion KRW | 5.53% |
2022 FY | 932.02 Billion KRW | 5.45% |
2022 Q1 | 850.5 Billion KRW | -3.77% |
2021 Q2 | 855.1 Billion KRW | 3.33% |
2021 Q3 | 868.94 Billion KRW | 1.62% |
2021 FY | 883.84 Billion KRW | 6.4% |
2021 Q1 | 827.58 Billion KRW | -0.37% |
2021 Q4 | 883.84 Billion KRW | 1.71% |
2020 Q3 | 826.69 Billion KRW | 2.99% |
2020 Q4 | 830.64 Billion KRW | 0.48% |
2020 Q2 | 802.67 Billion KRW | 2.87% |
2020 FY | 830.64 Billion KRW | 4.78% |
2020 Q1 | 780.24 Billion KRW | -1.58% |
2019 Q3 | 762.04 Billion KRW | -0.29% |
2019 Q1 | 755.27 Billion KRW | 3.17% |
2019 FY | 792.77 Billion KRW | 8.29% |
2019 Q2 | 764.29 Billion KRW | 1.19% |
2019 Q4 | 792.77 Billion KRW | 4.03% |
2018 Q1 | 727.04 Billion KRW | 0.6% |
2018 Q3 | 739.89 Billion KRW | 0.77% |
2018 FY | 732.05 Billion KRW | 1.29% |
2018 Q4 | 732.05 Billion KRW | -1.06% |
2018 Q2 | 734.21 Billion KRW | 0.99% |
2017 FY | 722.69 Billion KRW | 6.31% |
2017 Q2 | 704.58 Billion KRW | 1.71% |
2017 Q4 | 722.69 Billion KRW | 0.48% |
2017 Q3 | 719.26 Billion KRW | 2.08% |
2017 Q1 | 692.71 Billion KRW | 1.9% |
2016 Q1 | 672.46 Billion KRW | 1.31% |
2016 Q2 | 677.6 Billion KRW | 0.76% |
2016 Q3 | 686.18 Billion KRW | 1.27% |
2016 Q4 | 679.78 Billion KRW | -0.93% |
2016 FY | 679.78 Billion KRW | 2.41% |
2015 Q1 | 645.45 Billion KRW | 45.86% |
2015 Q4 | 663.78 Billion KRW | -1.08% |
2015 Q3 | 671.01 Billion KRW | 4.0% |
2015 FY | 663.78 Billion KRW | 50.0% |
2015 Q2 | 645.19 Billion KRW | -0.04% |
2014 Q3 | 438.48 Billion KRW | -0.34% |
2014 Q2 | 439.96 Billion KRW | 2.76% |
2014 FY | 442.52 Billion KRW | 3.96% |
2014 Q4 | 442.52 Billion KRW | 0.92% |
2014 Q1 | 428.16 Billion KRW | 0.58% |
2013 Q4 | 425.67 Billion KRW | 2.22% |
2013 Q2 | 411.97 Billion KRW | 0.15% |
2013 Q1 | 411.37 Billion KRW | 5.63% |
2013 FY | 425.67 Billion KRW | 9.31% |
2013 Q3 | 416.42 Billion KRW | 1.08% |
2012 Q1 | 318.03 Billion KRW | 0.0% |
2012 FY | 389.43 Billion KRW | 21.06% |
2012 Q4 | 389.43 Billion KRW | 0.0% |
2011 FY | 321.68 Billion KRW | 10.28% |
2011 Q3 | 305.64 Billion KRW | 0.1% |
2011 Q2 | 305.35 Billion KRW | 2.22% |
2011 Q1 | 298.73 Billion KRW | 2.42% |
2010 Q4 | 291.68 Billion KRW | 3.91% |
2010 Q3 | 280.69 Billion KRW | 2.0% |
2010 FY | 291.68 Billion KRW | 10.52% |
2010 Q1 | 265.83 Billion KRW | 0.72% |
2010 Q2 | 275.18 Billion KRW | 3.51% |
2009 Q1 | 248.12 Billion KRW | 0.52% |
2009 FY | 263.92 Billion KRW | 6.92% |
2009 Q4 | 263.92 Billion KRW | 1.17% |
2009 Q3 | 260.87 Billion KRW | 2.5% |
2009 Q2 | 254.52 Billion KRW | 2.58% |
2008 Q1 | 233.42 Billion KRW | -1.85% |
2008 Q2 | 245.26 Billion KRW | 5.07% |
2008 Q3 | 250.8 Billion KRW | 2.26% |
2008 Q4 | 246.84 Billion KRW | -1.58% |
2008 FY | 246.84 Billion KRW | 3.8% |
2007 Q1 | 224.37 Billion KRW | 0.0% |
2007 FY | 237.81 Billion KRW | 0.0% |
2007 Q3 | 246.37 Billion KRW | 5.52% |
2007 Q2 | 233.49 Billion KRW | 4.06% |
2007 Q4 | 237.81 Billion KRW | -3.48% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Yuyu Pharma, Inc. | 198.21 Billion KRW | -443.891% |
Dong-A Socio Holdings Co., Ltd. | 1957.1 Billion KRW | 44.915% |
Ildong Holdings Co., Ltd. | 876.99 Billion KRW | -22.927% |
HANDOK Inc. | 790.33 Billion KRW | -36.405% |
Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -531.852% |
Yuhan Corporation | 2814.07 Billion KRW | 61.69% |
Dong-A ST Co., Ltd. | 1315.21 Billion KRW | 18.032% |
SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -1053.27% |
Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | 44.772% |
Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -349.668% |
Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -129.912% |
Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -837.666% |
MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -355.748% |
Hana Pharm Co., Ltd. | 348.38 Billion KRW | -209.446% |
Yuyu Pharma, Inc. | 198.21 Billion KRW | -443.891% |
Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -157.178% |
REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -115.71% |
Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -82.91% |
JW Holdings Corporation | 1176.26 Billion KRW | 8.349% |
Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -76.367% |
Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | 23.129% |
JW Pharmaceutical Corporation | 645.03 Billion KRW | -67.132% |
Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -207.945% |
Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -599.856% |
Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -190.834% |
Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -121.22% |
Yuyu Pharma, Inc. | 198.21 Billion KRW | -443.891% |
Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | 39.103% |
JW Pharmaceutical Corporation | 645.03 Billion KRW | -67.132% |
Yuhan Corporation | 2814.07 Billion KRW | 61.69% |
Jeil Pharma Holdings Inc | 879.99 Billion KRW | -22.508% |
Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -375.755% |
Suheung Co., Ltd. | 993.73 Billion KRW | -8.486% |
JW Pharmaceutical Corporation | 645.03 Billion KRW | -67.132% |
Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -156.743% |
Korea United Pharm Inc. | 468.86 Billion KRW | -129.933% |
CKD Bio Corp. | 293.78 Billion KRW | -266.957% |
Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -112.218% |
Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -90.817% |
Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -168.692% |
Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -207.945% |
Chong Kun Dang Holdings Corp. | 1456 Billion KRW | 25.957% |
Boryung Corporation | 922.36 Billion KRW | -16.881% |
Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -143.652% |
Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -129.912% |
JW Lifescience Corporation | 255.83 Billion KRW | -321.389% |